세계의 가축 백신 시장 규모 : 백신 유형별, 대상 동물 종별, 투여 방법별, 최종 사용자별, 지역별 범위와 예측
Global Farm Animal Vaccine Market Size By Type Of Vaccine, By Target Animal Species, By Administration Method, By End-User, By Geographic Scope And Forecast
상품코드:1736503
리서치사:Verified Market Research
발행일:2025년 05월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
한글목차
가축 백신 시장 규모와 예측
가축 백신 시장 규모는 2024년에는 95억 달러로 평가되었고, 2026-2032년에 걸쳐 CAGR 7.25%를 나타내 2032년에는 166억 3,000만 달러에 달할 것으로 예측되고 있습니다.
세계의 가축 백신 시장 성장 촉진요인
가축 백신 시장 성장 촉진요인은 다양한 요인의 영향을 받을 수 있습니다.
동물성 단백질에 대한 요구 증가 : 세계 인구가 증가함에 따라 고기와 유제품에 대한 수요가 증가하고 있습니다.
가축의 질병의 만연 : 축산업은 구제역, 조류 인플루엔자, 돼지 번식·호흡기 증후군(PRRS) 등의 질병에 의해 큰 경제적 손실을 입을 가능성이 있습니다.
정부의 이니셔티브와 법률 : 동물 질병의 확산을 막기 위해 정부와 규제 기관은 자주 프로그램과 법률을 제정합니다.
기술 개발 : 생명공학과 백신 연구 개발로 보다 뛰어난 안전한 백신접종이 가능해졌습니다.
동물 위생에 대한 투자 증가 : 가축 백신 시장은 동물 건강 관리를 지원하는 인프라에 대한 투자 증가와 동물의 건강과 복지의 중요성에 대한 의식이 증가함에 따라 확대되고 있습니다.
무역의 세계화 : 무역이 확대됨에 따라 질병이 국제적으로 확산 될 가능성이 커지고 있으며, 그 결과 새로운 지역에 질병의 도입과 확산을 막기 위해 예방 접종 캠페인이 더욱 중요 해지고 있습니다.
인간 짐승 공통 감염은 동물에서 사람으로 감염될 가능성이 있는 감염증으로 보다 일반적으로 되고 있습니다.
예방 건강 관리로의 전환 : 축산업의 추세로 농업 종사자는 질병 치료보다 예방에 중점을두고 있습니다.
집중농법의 채용 확대 : 가축은 밀접하게 사육되기 때문에 농후 사료 시설(CAFO)과 같은 집약적 농법은 질병 발생의 위험성을 높이고 있습니다.
세계의 가축 백신 시장 성장 억제요인
가축 백신 시장에는 몇 가지 요인이 억제요인이나 과제로 작용할 수 있습니다.
규제 어려움 : 백신 인가 절차는 시간이 많이 걸리고 엄격하기 때문에 시장 도입과 성장에 지연이 발생할 수 있습니다.
고가의 개발비 : 가축 백신 개발과 관련된 R&D 비용은 시장 진출기업을 제한하고 백신 가격을 높일 수 있습니다.
제한된 지식 : 일부 지역에서는 가축에 대한 백신 접종의 이점을 모르는 농업 종사자와 그 효과에 대해 의심하는 농업 종사자가 시장 성장을 방해할 수 있습니다.
인프라 과제 : 백신의 유통, 투여 및 보관을 위한 인프라가 충분하지 않기 때문에 특히 신흥국에서는 개발이 저해될 수 있습니다.
하위 세분화된 시장 : 소규모 생산자가 많기 때문에 가축 백신 시장이 세분화되어 가격 상승의 압력이 되고 기술 혁신이 제한될 수 있습니다.
질병 관리 기술 : 특정 농업 경영에서 항생제 사용 및 바이오 보안 대책과 같은 효과적인 질병 관리 기술은 예방 접종의 필요성을 분명히 줄일 수 있습니다.
전통적 의약품과의 경쟁 : 시장에 따라 백신은 항생제와 한약 등 전통적 질병 예방 및 치료 수단과의 경쟁에 직면할 수 있습니다.
경제적 요인 : 농업 종사자가 백신 및 기타 예방 조치에 지출하는 능력은 경제 침체 및 상품 가격 변동에 의해 영향을 받을 수 있습니다.
과다사용에 대한 우려 : 백신의 과도한 사용은 예방접종에 내성이 있는 질병주가 나타나거나 가축의 건강에 악영향을 미칠 수 있습니다.
변화에 대한 저항 : 농업 종사자와 농업 커뮤니티 중 일부는 예방접종과 같은 새로운 기술과 관행을 도입하는 것에 저항할 수 있으며 시장 확대를 방해할 수 있습니다.
목차
제1장 세계의 가축 백신 시장 서론
시장 개요
조사 범위
전제조건
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH의 조사 방법
데이터 마이닝
밸리데이션
1차 자료
데이터 소스 일람
제4장 세계의 가축 백신 시장 전망
개요
시장 역학
성장 촉진요인
성장 억제요인
기회
Porter's Five Forces 모델
밸류체인 분석
제5장 세계의 가축 백신 시장 : 백신 유형별
약독화 생백신
불활성화 백신
서브 유닛 백신
DNA 백신
제6장 세계의 가축 백신 시장 : 대상 동물 종별
소
돼지
가금류
양 및 염소
제7장 세계의 가축 백신 시장 : 투여 방법별
주사용 백신
경구용 백신
비강 내 백신
제8장 세계의 가축 백신 시장 : 최종 사용자별
동물병원 및 클리닉
가축 생산자
수의 진단 실험실
동물보건회사
제9장 세계의 가축 백신 시장 : 지역별
개요
북미
미국
캐나다
멕시코
유럽
독일
영국
프랑스
기타 유럽
아시아태평양
중국
일본
인도
기타 아시아태평양
기타
라틴아메리카
중동 및 아프리카
제10장 세계의 가축 백신 시장 경쟁 구도
개요
각사 시장 랭킹
주요 개발 전략
제11장 기업 프로파일
Boehringer Ingelheim
Merck
Zoetis
WINSUN
Ringpu Biology
Ceva
CAHIC
HVRI
Bio-Labs
Yebio
제12장 부록
관련 조사
KTH
영문 목차
영문목차
Farm Animal Vaccine Market Size And Forecast
Farm Animal Vaccine Market size was valued at USD 9.5 USD Billion in 2024 and is projected to reach USD 16.63 USD Billion by 2032, growing at a CAGR of 7.25% during the forecast period 2026-2032.
Global Farm Animal Vaccine Market Drivers
The market drivers for the Farm Animal Vaccine Market can be influenced by various factors. These may include:
Growing Need for Animal Protein: The demand for meat and dairy products rises in tandem with the growth of the world's population. Because of this, there is a greater requirement for healthy farm animals, which raises the need for vaccinations to stave off illnesses that could lower livestock productivity.
Animal illness prevalence: The cattle business can suffer large financial losses as a result of diseases including foot-and-mouth disease, avian influenza, and porcine reproductive and respiratory syndrome (PRRS). The need for vaccines for agricultural animals is fueled by the critical role immunizations play in both preventing and controlling these diseases.
Government Initiatives and laws: To stop the spread of animal diseases, governments and regulatory agencies frequently put programs and laws into place. This includes immunization campaigns, which generate a consistent need for vaccines for farm animals.
Technological developments: Better and safer vaccinations for farm animals have been made possible by developments in biotechnology and vaccine research. These developments stimulate the market's creativity and aid in its expansion.
Increasing Investments in Animal Health: The market for farm animal vaccines is expanding as a result of rising investments in the infrastructure supporting animal healthcare as well as growing awareness of the significance of animal health and welfare.
Trade Globalization: As trade grows, there is a greater chance that diseases will spread internationally. As a result, immunization campaigns are more important to stop the introduction and spread of illnesses to new areas.
Zoonotic diseases are infections that can spread from animals to people and are becoming more common. The need for farm animal vaccines is fueled by the fact that immunizing animals against certain illnesses not only protects them but also lowers the possibility of human infection.
Transition to Preventive Healthcare: Farmers are putting more of an emphasis on preventing illnesses than treating them as a result of a growing tendency in animal husbandry. This promotes vaccination programs' uptake and expands the market for vaccines intended for agricultural animals.
Growing Adoption of Intensive Farming Practices: Because animals are kept in close quarters, intensive farming methods-like concentrated animal feeding operations (CAFOs)-increase the danger of disease outbreaks. Because vaccinations are crucial in stopping the spread of disease in these kinds of settings, there is an increased need for farm animal vaccines.
Global Farm Animal Vaccine Market Restraints
Several factors can act as restraints or challenges for the Farm Animal Vaccine Market. These may include:
Regulatory Difficulties: The lengthy and rigorous regulatory licensing procedures for vaccines might cause delays in the introduction or growth of the market.
High Development expenditures: Research and development expenditures associated with developing vaccines for farm animals might restrict market participants and drive up vaccine pricing.
Limited Knowledge: The growth of the market may be hampered in some areas by farmers who are unaware of the advantages of vaccinations for their animals or who have doubts about their effectiveness.
Infrastructure Challenges: Inadequate infrastructure for the distribution, administration, and storage of vaccines might obstruct market expansion in some areas, particularly in developing nations.
Fragmented Market: Due to the large number of small-scale producers, the market for farm animal vaccines may be fragmented, which could put pressure on prices and restrict innovation.
Disease Control techniques: In certain farming operations, the apparent need for vaccinations may be lessened by effective disease control techniques such the use of antibiotics and biosecurity measures.
Competition from Traditional Medicines: In certain markets, vaccines may face competition from traditional means of illness prevention and treatment, such as antibiotics or herbal medicines.
Economic Factors: Farmers' capacity to spend in vaccines and other preventive measures may be impacted by downturns in the economy or changes in commodity prices.
Concerns regarding Overuse: There may be worries that using vaccines excessively could result in the emergence of disease strains resistant to vaccinations or have a negative impact on the health of animals.
Resistance to Change: Some farmers or farming communities may be resistant to implementing new technologies or practices, such as vaccinations, which could impede the expansion of the market.
Global Farm Animal Vaccine Market Segmentation Analysis
The Global Farm Animal Vaccine Market is Segmented on the basis of Type of Vaccine, Target Animal Species, Administration Method, End-User, and Geography.
Farm Animal Vaccine Market, By Type of Vaccine
Live Attenuated Vaccines: Vaccines containing weakened forms of the pathogen that stimulate an immune response in animals without causing disease, providing long-lasting immunity with a single dose.
Inactivated Vaccines: Vaccines containing killed or inactivated pathogens, which require multiple doses or booster shots to induce immunity but are safer for use in pregnant animals and young animals with developing immune systems.
Subunit Vaccines: Vaccines composed of specific antigens or proteins from the pathogen, offering targeted immune responses with reduced risk of adverse reactions compared to whole-cell vaccines.
DNA Vaccines: Vaccines that deliver genetic material encoding antigenic proteins into animal cells, stimulating both humoral and cellular immune responses for long-term protection against pathogens.
Farm Animal Vaccine Market, By Target Animal Species
Cattle: Vaccines developed specifically for cattle to prevent diseases such as bovine respiratory disease (BRD), bovine viral diarrhea (BVD), infectious bovine rhinotracheitis (IBR), and clostridial infections.
Pigs: Vaccines designed for pigs to protect against diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, porcine circovirus-associated diseases (PCVAD), and classical swine fever.
Poultry: Vaccines formulated for poultry species including chickens, turkeys, and ducks to prevent diseases such as Newcastle disease, infectious bronchitis, avian influenza, Marek's disease, and infectious bursal disease.
Sheep and Goats: Vaccines tailored for sheep and goats to control diseases such as foot-and-mouth disease (FMD), enterotoxemia, clostridial infections, and contagious ecthyma (orf).
Farm Animal Vaccine Market, By Administration Method
Injectable Vaccines: Vaccines administered through injection into muscle tissue or under the skin, providing targeted delivery and reliable immune responses.
Oral Vaccines: Vaccines administered orally through feed or drinking water, offering ease of administration and potential for mass vaccination of large animal populations.
Intranasal Vaccines: Vaccines delivered through the nasal passages, stimulating mucosal immunity and providing protection against respiratory pathogens in farm animals.
Farm Animal Vaccine Market, By End-User
Veterinary Hospitals and Clinics: Facilities providing veterinary services and healthcare to farm animals, including vaccination programs, preventive care, and treatment of infectious diseases.
Livestock Producers: Farmers, ranchers, and livestock producers responsible for managing the health and well-being of farm animals, including implementing vaccination protocols and disease prevention strategies.
Veterinary Diagnostic Laboratories: Laboratories conducting diagnostic tests, serological assays, and vaccine efficacy studies to monitor disease prevalence, assess vaccine effectiveness, and guide vaccination strategies.
Animal Health Companies: Manufacturers and suppliers of farm animal vaccines, veterinary pharmaceuticals, and biological products, offering a range of vaccine formulations and solutions for disease prevention and control.
Farm Animal Vaccine Market, By Geographic
North America: Market dynamics and trends specific to the farm animal vaccine industry in North American regions, including the United States, Canada, and Mexico.
Europe: Market factors and regulatory influences shaping the farm animal vaccine market across European countries such as the UK, Germany, France, and Italy.
Asia Pacific: Growth opportunities and market expansion strategies relevant to farm animal vaccines in countries like China, India, Japan, and Australia.
Latin America: Market trends and consumer preferences impacting the farm animal vaccine market in Latin American regions like Brazil, Argentina, and Chile.
Middle East and Africa: Factors driving demand for farm animal vaccines in regions like the Middle East and Africa, including increasing livestock production, disease outbreaks, and government initiatives for animal health.
Key Players
The major players in the Farm Animal Vaccine Market are:
Elanco
Virbac
Vetoquinol S.A.
4Hester Biosciences Limited
Phibro Animal Health Corporation
HIPRA
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL FARM ANIMAL VACCINE MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL FARM ANIMAL VACCINE MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL FARM ANIMAL VACCINE MARKET, BY TYPE OF VACCINE
5.1 Live Attenuated Vaccines
5.2 Inactivated Vaccines
5.3 Subunit Vaccines
5.4 DNA Vaccines
6 GLOBAL FARM ANIMAL VACCINE MARKET, BY TARGET ANIMAL SPECIES
6.1 Cattle
6.2 Pigs
6.3 Poultry
6.4 Sheep and Goats
7 GLOBAL FARM ANIMAL VACCINE MARKET, BY ADMINISTRATION METHOD
7.1 Injectable Vaccines
7.2 Oral Vaccines
7.3 Intranasal Vaccines
8 GLOBAL FARM ANIMAL VACCINE MARKET, BY END-USER
8.1 Veterinary Hospitals and Clinics
8.2 Livestock Producers
8.3 Veterinary Diagnostic Laboratories
8.4 Animal Health Companies
9 GLOBAL FARM ANIMAL VACCINE MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North America
9.2.1 U.S.
92.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.2 Middle East And Africa
10 GLOBAL FARM ANIMAL VACCINE MARKET COMPETITIVE LANDSCAPE
